Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2022-12-16 2023-01-26 178754
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-01-20 2023-01-26 181970
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-02 2023-03-16 183480
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-02-09 2023-03-16 184089
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-06 2023-05-26 191877
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-05-19 2023-06-09 192796
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-07 2023-09-15 197879
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-07-13 2023-11-06 198525
APO-LANSOPRAZOLE 15MG CAPSULE (DELAYED RELEASE) Resolved 2023-10-20 2023-11-06 207716
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-11-06 2023-11-24 209348
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2023-12-22 2024-02-02 214215
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Resolved 2024-04-19 2024-05-03 225761
APO-LAMOTRIGINE 150MG TABLET Resolved 2019-01-03 2019-03-01 71130
APO-LAMOTRIGINE 150MG TABLET Resolved 2019-08-07 2019-08-21 91081
APO-LAMOTRIGINE 25MG TABLET Resolved 2019-09-04 2020-01-29 92978
APO-LAMOTRIGINE 100MG TABLET Resolved 2020-02-05 2020-03-27 105345
APO-LAMOTRIGINE 100MG TABLET TABLET Resolved 2020-05-08 2020-06-15 114288
APO-LAMOTRIGINE 150MG TABLET Resolved 2020-10-28 2020-12-07 127347
APO-LAMOTRIGINE 100MG TABLET TABLET Resolved 2020-12-11 2021-02-01 130045
APO-LAMOTRIGINE 150MG TABLET Resolved 2020-12-18 2021-02-01 130404

Showing 1681 to 1700 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950

Showing 81 to 100 of 356